The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Martin Bergmann
Showing 1-13 of 13 articles
The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction
Paitazoglou C,
Özdemir R,
Pfister R,
Bergmann M,
Bartunek J,
Kilic T,
Lauten A,
Schmeisser A,
Zoghi M,
Anker S,
Sievert H,
Mahfoud F
August 29, 2019 | 10.4244/EIJ-D-19-00342
European registry data on LAA closure: advancing the field of interventional stroke prevention
Bergmann M
June 20, 2018 | 10.4244/EIJV14I2A20
Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study
Bergmann M,
Ince H,
Kische S,
Schmitz T,
Meincke F,
Schmidt B,
Foley DP,
Betts TR,
Grygier M,
Protopopov A,
Stein KM,
Boersma L
April 20, 2018 | 10.4244/EIJ-D-17-00672
Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registry
Bergmann M,
Betts TR,
Sievert H,
Schmidt B,
Pokushalov E,
Kische S,
Schmitz T,
Meincke F,
Stein KM,
Boersma L,
Ince H
September 20, 2017 | 10.4244/EIJ-D-17-00042
Left atrial appendage closure: patient, device and post-procedure drug selection
Tzikas A,
Bergmann M
May 16, 2016 | 10.4244/EIJV12SXA10
Safety and efficacy of lesion preparation with the AngioSculpt Scoring Balloon in left main interventions: the ALSTER Left Main registry
Schmidt T,
Hansen S,
Meincke F,
Frerker C,
Kuck K,
Bergmann M
March 18, 2016 | 10.4244/EIJY15M05_04
Delayed coverage of drug-eluting stents after interventional revascularisation of chronic total occlusions assessed by optical coherence tomography: the ALSTER-OCT-CTO registry
Heeger C-H,
Busjahn A,
Hildebrand L,
Fenski M,
Lesche F,
Meincke F,
Kuck K,
Bergmann M
January 20, 2016 | 10.4244/EIJY14
Twelve-month results of the Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the OneShot™ Ablation System (RAPID) study
Verheye S,
Ormiston J,
Bergmann M,
Sievert H,
Schwindt A,
Werner N,
Vogel B,
Colombo A
February 20, 2015 | 10.4244/EIJY14M12_02
Percutaneous left atrial appendage closure in patients with left atrial appendage thrombus
Meincke F,
Kreidel F,
Von Wedel J,
Schäfer U,
Kuck K,
Bergmann M
February 20, 2015 | 10.4244/EIJV10I10A199
Left atrial appendage closure for stroke prevention in non-valvular atrial fibrillation: rationale, devices in clinical development and insights into implantation techniques
Bergmann M,
Landmesser U
August 19, 2014 | 10.4244/EIJV10I4A86
Results of the ALSTER BP real-world registry on renal denervation employing the Symplicity system
Kaiser L,
Beister T,
Wiese A,
Von Wedel J,
Meincke F,
Kreidel F,
Busjahn A,
Kuck K,
Bergmann M
May 20, 2014 | 10.4244/EIJV10I1A24
New technical and anticoagulation aspects for left atrial appendage closure using the WATCHMAN® device in patients not taking warfarin
Meincke F,
Schmidt-Salzmann M,
Kreidel F,
Kuck K,
Bergmann M
August 23, 2013 | 10.4244/EIJV9I4A75
Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trial
Heeger C-H,
Jaquet K,
Thiele H,
Zulkarnaen Y,
Cuneo A,
Haller D,
Kivelitz D,
Schmidt T,
Krause K,
Metzner A,
Schneider C,
Kuck K,
Bergmann M
October 26, 2012 | 10.4244/EIJV8I6A113
1
Latest news
AHEAD OF PRINT
Delayed hospitalisation in the MITRA-FR trial
FREE ARTICLE - Guillaume Leurent et al
May 25, 2022
EUROPCR LATE BREAKING
EuroPCR 2022 Late-breaking publications: watch the interviews with the authors!
May 23, 2022
NEW ISSUE
TAVI vs SAVR for bicuspid anatomies; PVR and TAVI; LAA thrombus trapping; crush techniques for bifurcation PCIs; stent elongation in POT and more
May 18, 2022
AHEAD OF PRINT
Complete cerebral protection during TAVI
FREE ARTICLE - Dariusz Jagielak et al
May 24, 2022
AHEAD OF PRINT
Outcomes of PCI for stent thrombosis
FREE ARTICLE - Mohamed O. Mohamed et al
May 24, 2022
EUROPCR LATE BREAKING
Changes in voice patterns for monitoring heart failure deterioration
FREE ARTICLE - Chaim Lotan et al
May 24, 2022
EUROPCR LATE BREAKING
SavvyWire in TAVI
FREE ARTICLE - Josep Rodés-Cabau et al
May 24, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke